Palatin Technologies PE ratio PTN

Share price divided by earnings per share over the last twelve months, since 2017.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 2.7×; Sep 2020
9-year median: 7.4×
9-year range: 2.4× to 27.0×
Peer median: 10.1×

Palatin Technologies has no meaningful PE ratio today: it lost $0.08 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Sep 2020, at 2.7×.

On the days it had one over the last 9 years, its median was 7.4×, from 2.4× in Mar 2020 to 27.0× in Nov 2018.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2020	2.7×	2.4×	4.5×
2019	4.7×	4.5×	25.7×
2018	23.3×	7.2×	27.0×
2017	21.5×	21.0×	25.0×

Against its peers

Companies in Drug Manufacturers - General nearest Palatin Technologies' size, closest first, today.

Company	PE ratio
PTNPalatin Technologies	n/m
ATNMActinium Pharmaceuticals	4.2×
SPROSpero Therapeutics	10.1×
LFVNLifevantage	14.7×
Peer median	10.1×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Palatin Technologies

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.